用CRISPR技术诊断和治疗人类牛病
Cia-Hin Lau1, Xiaojun Li2, Qing-Le Liang3
1Department of Biology, College of Science, Shantou University, Shantou, Guangdong, China.
Journal of microbiological methods
|November 22, 2025
概括
新兴的CRISPR/Dx技术为在动物和人类中快速,可在现场部署的布鲁塞拉检测提供了一个有希望的解决方案. 本综述探讨了其用于准确诊断和新型治疗的潜力,克服了当前方法的局限性.
科学领域:
- 微生物学 微生物学
- 生物技术是生物技术.
- 兽医医学 兽医医学 兽医医学
背景情况:
- 布鲁塞拉感染对全球健康和经济造成重大负担,特别是在发展中国家.
- 目前布鲁塞洛斯的诊断方法 (PCR,培养,血清学) 受到长时间,低灵敏度,可变性和高成本的限制.
- 需要快速,可访问和准确的布鲁塞拉检测和治疗策略至关重要.
研究的目的:
- 审查CRISPR/Dx技术在牲畜中的现场部署布鲁塞拉诊断和在人类的临床试验中的应用.
- 讨论CRISPR技术作为治疗布鲁塞洛斯病的治疗策略的潜力,特别是针对多药耐药菌株.
- 批判性地评估基于CRISPR的解决方案的进展,挑战和未来前景.
主要方法:
- 审查关于CRISPR/Dx技术及其在病原体检测中的应用的当前文献.
- 对CRISPR基因编辑机制进行分析,以对抗布鲁塞拉病毒的潜在治疗干预.
- 讨论基于CRISPR的诊断与传统方法的比较优势和局限性.
主要成果:
- 克里斯帕/Dx技术展示了快速,灵敏和可在现场部署的布鲁塞拉检测的潜力,解决了传统测试的局限性.
- 基于CRISPR的治疗方法在准布鲁塞拉复制和存活方面表现有前途,为传统抗生素提供了替代方案.
- 这项技术有助于开发人体血病的临床检测和家用动物的诊断.
结论:
- 克里斯普尔/Dx技术代表了布鲁塞洛症诊断的重大进步,使得现场和家庭测试成为可能.
- 在治疗中使用CRISPR提供了一种新的策略来对抗乳头病,特别是在抗生素耐药性的情况下.
- 进一步完善CRISPR技术至关重要,以充分发挥其在减轻布鲁塞拉感染全球影响方面的潜力.
相关概念视频
CRISPR
57.4K
Genome editing technologies allow scientists to modify an organism’s DNA via the addition, removal, or rearrangement of genetic material at specific genomic locations. These types of techniques could potentially be used to cure genetic disorders such as hemophilia and sickle cell anemia. One popular and widely used DNA-editing research tool that could lead to safe and effective cures for genetic disorders is the CRISPR-Cas9 system. CRISPR-Cas9 stands for Clustered Regularly Interspaced...
57.4K
CRISPR/Cas9 Genome Editing
1.6K
The CRISPR-Cas system serves as a bacterial defense mechanism against invading genetic elements such as viruses and plasmids, forming the foundation for its adaptation as a powerful genome-editing tool. Originally discovered in prokaryotes, this system has been repurposed to revolutionize genetic engineering across a wide range of organisms, including plants, animals, and humans. The core component, Cas9, is an endonuclease derived from Streptococcus pyogenes, capable of introducing...
1.6K
CRISPR and crRNAs
18.7K
Bacteria and archaea are susceptible to viral infections just like eukaryotes; therefore, they have developed a unique adaptive immune system to protect themselves. Clustered regularly interspaced short palindromic repeats and CRISPR-associated proteins (CRISPR-Cas) are present in more than 45% of known bacteria and 90% of known archaea.
The CRISPR-Cas system stores a copy of foreign DNA in the host genome and uses it to identify the foreign DNA upon reinfection. CRISPR-Cas has three different...
The CRISPR-Cas system stores a copy of foreign DNA in the host genome and uses it to identify the foreign DNA upon reinfection. CRISPR-Cas has three different...
18.7K


